{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:56:59Z","timestamp":1791961019441,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T00:00:00Z","timestamp":1163808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,3,20]]},"DOI":"10.1007\/s00417-006-0461-9","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T08:09:10Z","timestamp":1163750950000},"page":"522-533","source":"Crossref","is-referenced-by-count":35,"title":["Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height"],"prefix":"10.1007","volume":"245","author":[{"given":"Ilkka","family":"Puusaari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,18]]},"reference":[{"key":"461_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","volume":"317","author":"DG Altman","year":"1998","unstructured":"Altman DG (1998) Confidence intervals for the number needed to treat. BMJ 317:1309\u20131312","journal-title":"BMJ"},{"key":"461_CR2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0161-6420(02)01273-3","volume":"109","author":"NE Bechrakis","year":"2002","unstructured":"Bechrakis NE, Bornfeld N, Zoller I, Foerster MH (2002) Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology 109:1855\u20131861","journal-title":"Ophthalmology"},{"key":"461_CR3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0197-2456(00)00134-3","volume":"22","author":"R Bender","year":"2001","unstructured":"Bender R (2001) Calculating confidence intervals for the number needed to treat. Control Clin Trials 22:102\u2013110","journal-title":"Control Clin Trials"},{"key":"461_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9394(02)02292-4","volume":"136","author":"DH Char","year":"2003","unstructured":"Char DH, Bove R, Phillips TL (2003) Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. Am J Ophthalmol 136:180\u2013182","journal-title":"Am J Ophthalmol"},{"key":"461_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajo.2004.04.070","volume":"138","author":"DH Char","year":"2004","unstructured":"Char DH, Miller T, Crawford JB (2004) Analysis of melanoma cell type in uveal melanoma following treatment failure. Am J Ophthalmol 138:543\u2013546","journal-title":"Am J Ophthalmol"},{"key":"461_CR6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9394(98)00038-5","volume":"125","author":"Collaborative Ocular Melanoma Study Group","year":"1998","unstructured":"Collaborative Ocular Melanoma Study Group (1998) The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9. Am J Ophthalmol 125:767\u2013778","journal-title":"Am J Ophthalmol"},{"key":"461_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000425695","volume":"30","author":"B Damato","year":"1997","unstructured":"Damato B (1997) Adjunctive plaque radiotherapy after local resection of uveal melanoma. Front Radiat Ther Oncol 30:123\u2013132","journal-title":"Front Radiat Ther Oncol"},{"key":"461_CR8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0161-6420(02)01240-X","volume":"109","author":"B Damato","year":"2002","unstructured":"Damato B, Groenewald CP, McGalliard JN, Wong D (2002) Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma. Ophthalmology 109:2137\u20132143","journal-title":"Ophthalmology"},{"key":"461_CR9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ophtha.2003.09.028","volume":"111","author":"B Damato","year":"2004","unstructured":"Damato B, Lecuona K (2004) Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 111:977\u2013983","journal-title":"Ophthalmology"},{"key":"461_CR10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/bjo.77.10.616","volume":"77","author":"BE Damato","year":"1993","unstructured":"Damato BE, Paul J, Foulds WS (1993) Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol 77:616\u2013623","journal-title":"Br J Ophthalmol"},{"key":"461_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.80.2.102","volume":"80","author":"BE Damato","year":"1996","unstructured":"Damato BE, Paul J, Foulds WS (1996) Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 80:102\u2013108","journal-title":"Br J Ophthalmol"},{"key":"461_CR12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archopht.1996.01100140557006","volume":"114","author":"P Potter De","year":"1996","unstructured":"De Potter P, Shields CL, Shields JA, Cater JR, Brady LW (1996) Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol 114:1357\u20131365","journal-title":"Arch Ophthalmol"},{"key":"461_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","volume":"112","author":"ET Detorakis","year":"2005","unstructured":"Detorakis ET, Engstrom RE Jr, Wallace R, Straatsma BR (2005) Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology 112:505\u2013510","journal-title":"Ophthalmology"},{"key":"461_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"M Diener-West","year":"2001","unstructured":"Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR, The Collaborative Ocular Melanoma Study Group. (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 119:969\u2013982","journal-title":"Arch Ophthalmol"},{"key":"461_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"461_CR16","first-page":"513","volume-title":"Handbook of statistics in clinical oncologym","author":"TA Gooley","year":"2001","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE (2001) Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks. In: Crowley J (eds) Handbook of statistics in clinical oncology. Marcel Dekker, New York, pp 513\u2013523"},{"key":"461_CR17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","volume":"106","author":"ES Gragoudas","year":"1999","unstructured":"Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM (1999) Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 106:1571\u20131578","journal-title":"Ophthalmology"},{"key":"461_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archopht.117.2.170","volume":"117","author":"K Gunduz","year":"1999","unstructured":"Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 117:170\u2013177","journal-title":"Arch Ophthalmol"},{"key":"461_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","volume":"127","author":"K Gunduz","year":"1999","unstructured":"Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 127:579\u2013589","journal-title":"Am J Ophthalmol"},{"key":"461_CR20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","volume":"117","author":"K Gunduz","year":"1999","unstructured":"Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 117:609\u2013614","journal-title":"Arch Ophthalmol"},{"key":"461_CR21","volume-title":"Multivariate data analysis","author":"JF Hair Jr","year":"1998","unstructured":"Hair JF Jr, Tatham RL, Anderson RE, Black WC (1998) Multivariate data analysis, 5th. Prentice-Hall, Upper Saddle River","edition":"5"},{"key":"461_CR22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0161-6420(97)30025-6","volume":"104","author":"JW Harbour","year":"1997","unstructured":"Harbour JW, Char DH, Kroll S, Quivey JM, Castro J (1997) Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 104:1785\u20131792","journal-title":"Ophthalmology"},{"key":"461_CR23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.ophtha.2003.02.001","volume":"110","author":"T Kivel\u00e4","year":"2003","unstructured":"Kivel\u00e4 T, Puusaari I, Damato B (2003) Transscleral resection vs. iodine brachytherapy for choroidal malignant melanomas 6\u00a0millimeters or more in thickness: a matched case-control study. Ophthalmology 110:2235\u20132244","journal-title":"Ophthalmology"},{"key":"461_CR24","first-page":"2085","volume":"42","author":"T Kivel\u00e4","year":"2001","unstructured":"Kivel\u00e4 T, Eskelin S, M\u00e4kitie T, Summanen P (2001) Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci 42:2085\u20132093","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"461_CR25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(01)00748-5","volume":"108","author":"BM Melia","year":"2001","unstructured":"Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, Montague P, Moy CS, Schachat AP, Simpson ER, Straatsma BR, Vine AK, Weingeist TA, Collaborative Ocular Melanoma Study Group (2001) Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3\u00a0years. COMS report no. 16. Ophthalmology 108:348\u2013366","journal-title":"Ophthalmology"},{"key":"461_CR26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(92)31899-8","volume":"99","author":"S Packer","year":"1992","unstructured":"Packer S, Stoller S, Lesser ML, Mandel FS, Finger PT (1992) Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 99:767\u2013773","journal-title":"Ophthalmology"},{"key":"461_CR27","volume-title":"Survival analysis. A practical approach","author":"MKB Parmar","year":"1995","unstructured":"Parmar MKB, Machin D (1995) Survival analysis. A practical approach. Wiley, Chichester"},{"key":"461_CR28","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.04-0066","volume":"45","author":"I Puusaari","year":"2004","unstructured":"Puusaari I, Heikkonen J, Kivela T (2004) Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Invest Ophthalmol Vis Sci 45:3425\u20133434","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"461_CR29","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","volume":"111","author":"I Puusaari","year":"2004","unstructured":"Puusaari I, Heikkonen J, Kivela T (2004) Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 111:1768\u20131777","journal-title":"Ophthalmology"},{"key":"461_CR30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0161-6420(03)00661-4","volume":"110","author":"I Puusaari","year":"2003","unstructured":"Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivel\u00e4 T (2003) Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology 110:2223\u20132234","journal-title":"Ophthalmology"},{"key":"461_CR31","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","volume":"109","author":"CL Shields","year":"2002","unstructured":"Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J (2002) Plaque radiotherapy for large posterior uveal melanomas (>\u2009or=8-mm thick) in 354 consecutive patients. Ophthalmology 109:1838\u20131849","journal-title":"Ophthalmology"},{"key":"461_CR32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","volume":"118","author":"CL Shields","year":"2000","unstructured":"Shields CL, Shields JA, Cater J, Gunduz K, Miyamoto C, Micaily B, Brady LW (2000) Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 118:1219\u20131228","journal-title":"Arch Ophthalmol"},{"key":"461_CR33","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-006-0461-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0461-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:29Z","timestamp":1559072429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-006-0461-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,18]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3,20]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0461-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,18]]}}}